Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Minerva Neurosciences, Inc. (NERV)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 42,721,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of product candidates to treat patients suffering from central nervous system diseases. Co.'s primary product candidate is roluperidone, a compound it is developing for the treatment of negative symptoms in patients with schizophrenia. Co. holds the license to roluperidone from Mitsubishi Tanabe Pharma Corporation with the rights to develop, sell and import roluperidone globally, excluding most of Asia. Co. also has exclusive rights to develop and commercialize MIN-301, a compound for the treatment of Parkinson's disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 53,056 53,056
Total Sell Value $0 $0 $206,193 $206,193
Total People Sold 0 0 3 3
Total Sell Transactions 0 0 4 4
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 144
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ollier Michele Director   –       •       •   2016-12-12 4 OE $5.77 $1,169,603 I/I 202,634 4,690,906     -
   De Rubertis Francesco Director   –       •       •   2016-12-12 4 OE $5.77 $1,169,603 I/I 202,634 4,690,906     -
   Yucca (jersey) Slp 10% Owner   –       –       •   2016-12-12 4 OE $5.77 $1,169,603 I/I 202,634 4,690,906     -
   De Rubertis Francesco Director   –       •       •   2016-08-10 4 S $10.00 $10,000,000 I/I (1,000,000) 4,488,272     -
   Ollier Michele Director   –       •       •   2016-08-10 4 S $10.00 $10,000,000 I/I (1,000,000) 4,488,272     -
   Yucca (jersey) Slp 10% Owner   –       –       •   2016-08-10 4 S $10.00 $10,000,000 I/I (1,000,000) 4,488,272     -
   Kupfer David Director   –       •      –    2016-06-21 4 B $10.73 $299,603 I/I 27,935 27,935 2.1     -
   Kupfer David Director   –       •      –    2016-06-20 4 B $10.95 $303,398 D/D 27,700 209,188 2.39     -
   Kupfer David Director   –       •      –    2016-03-17 4 B $5.51 $999,999 D/D 181,488 181,488 2.39     -
   Johnson & Johnson Development Corp Et Al 10% Owner   –       –       •   2015-03-18 5 B $4.93 $2,996,962 I/I 607,903 3,892,256     -
   Care Capital Offshore Investments Iii Lp 10% Owner   –       –       •   2015-03-18 4 S $5.75 $6,941,875 I/I (1,206,700) 1,662,592     -
   Yucca (jersey) Slp 10% Owner   –       –       •   2015-03-18 4 B $4.81 $974,670 I/I 202,634 5,488,272 1.5     -
   Ollier Michele Director   –       •       •   2015-03-18 4 B $4.81 $974,670 I/I 202,634 5,488,272 2.25     -
   De Rubertis Francesco Director   –       •       •   2015-03-18 4 B $4.81 $974,670 I/I 202,634 5,488,272 2.25     -
   Johnson & Johnson Development Corp Et Al 10% Owner   –       –       •   2015-03-13 4 B $4.81 $2,924,013 I/I 607,903 4,500,159 1.5     -
   Care Capital Offshore Investments Iii Lp 10% Owner   –       –       •   2015-01-26 4 S $5.02 $116,017 I/I (23,111) 2,869,292     -
   Care Capital Offshore Investments Iii Lp 10% Owner   –       –       •   2015-01-23 4 S $5.14 $325,383 I/I (63,304) 2,892,403     -
   Care Capital Offshore Investments Iii Lp 10% Owner   –       –       •   2015-01-22 4 S $5.11 $2,022,012 I/I (395,697) 2,955,707     -
   Care Capital Offshore Investments Iii Lp 10% Owner   –       –       •   2015-01-08 4 S $5.66 $399,930 I/I (70,659) 3,351,404     -
   Care Capital Offshore Investments Iii Lp 10% Owner   –       –       •   2015-01-07 4 S $5.85 $376,026 I/I (64,278) 3,422,063     -
   Care Capital Offshore Investments Iii Lp 10% Owner   –       –       •   2015-01-06 4 S $7.94 $3,151,156 I/I (396,871) 3,486,341     -
   Johnson & Johnson Development Corp Et Al 10% Owner   –       –       •   2014-07-07 3 IO $0.00 $0 I/I 0 3,284,353     -
   Ollier Michele Director   –       •       •   2014-07-07 4 B $6.00 $9,724,998 I/I 1,620,833 5,285,638 2.25     -
   Ollier Michele Director   –       •       •   2014-07-07 4 OE $6.00 $1,055,994 I/I 175,999 3,664,805     -
   Yucca (jersey) Slp 10% Owner   –       –       •   2014-07-07 4 B $6.00 $9,724,998 I/I 1,620,833 5,285,638 1.5     -
  144 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us